ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer. Atlentis Therapeutics is developing breakthrough treatments for fibrotic disease and associated cancer.
Biotechnology, Therapeutics, medicaltech
Between €10 million-€25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Alentis Therapeutics? We’re happy to assist you with our Startup Sourcing service.